Changes in mouse breast tissue after exposure to fracking chemicals
The authors believe theirs is the first study to show that mouse mammary gland tissues are sensitive to a mixture of 23 commonly used UOG chemicals, with dose-specific effects on tissue morphology, cell proliferation and induction of intraductal hyperplasias, an overgrowth of cells considered a marker for future breast cancer risk. Details appear in the current issue of Endocrinology.
With more than 17 million Americans now living within one mile of an oil and gas well, there is concern about the possible contamination of surface and groundwater by trace metals, radioactive isotopes and other inorganic compounds released in these areas, they point out.
Vandenberg says, "This study shows that a mixture of UOG chemicals can affect the long-term health of the mouse mammary gland, even after low level exposures in the womb. These results are particularly interesting because they suggest harm from chemicals that have been poorly studied, but with likely widespread human exposures. Studying chemicals in mixtures also remains fairly rare, but it is an important research direction because most chemicals that humans encounter from the environment are found in complex mixtures."
She worked with reproductive biologist and endocrinologist Susan Nagel of the University of Missouri, Columbia, whose laboratory collected the mouse mammary tissue samples exposed to the UOG chemical mix. Most of these chemicals had previously been shown to have negative effects on one or more hormone receptors by Nagel's lab. Tissues were later analyzed by Vandenberg with undergraduate student and first author of the paper, Sarah Sapouckey.
Vandenberg and Nagel say the two lower doses they used are equivalent to the concentrations measured in drinking water in regions experiencing drilling, and the highest dose is equivalent to the concentrations of many UOG mixture components measured in industry wastewater. Concentrations for several of the 23 chemicals have not yet been determined in either drinking water or wastewater, they add.
For this work supported by the National Institute of Environmental Health Sciences, Nagel and colleagues treated groups of pregnant mice with one of four UOG doses or a control substance in their drinking water until their pups were born. Mammary tissue from female pups was then analyzed for a variety of endpoints on either postnatal day 21, prior to puberty, or 85, in early adulthood.
Overall, Vandenberg and colleagues report that prenatal exposure to the 23-chemical mixture did not alter morphology of the pups' mammary glands at Day 21, before they entered puberty.
However, the researchers report "a striking observation" in morphological assessment of the pups' now-adult mammary glands at Day 85. They saw structures resembling terminal end buds, mammary structures that are normally only found at puberty, in UOG-exposed but not in control samples. These structures were further examined by tissue-level and immunohistochemical tools, revealing ducts with "excessive layers" of epithelial cells, potentially pre-cancerous lesions that were "highly proliferative" compared to normal ducts, they add.
Vandenberg, Nagel and colleagues point out that their results "suggest that the mammary gland is sensitive to mixtures of chemicals used in UOG production at exposure levels that are environmentally relevant. The effect of these findings on the long-term health of the mammary gland, including its lactational capacity and its risk of cancer, should be evaluated in future studies."
The authors call for further studies "to evaluate the many additional chemicals used in, and produced by, UOG processes to better quantify the concentrations of these and other contaminants in environmental samples and to assess the effects of exposure during other sensitive windows of development, including pregnancy and lactation, puberty, and the aging female."
They also recommend investigating whether exposure to a UOG mix during development can sensitize animals to hormones or carcinogens.